Group One Trading
GBIO

Group One Trading’s Generation Bio GBIO Stock Holding History

Group One Trading’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-450
Closed -$17.1K – 7642
2023
Q3 		$17.1K Buy
450
+20
+5% +$947 ﹤0.01% 6001
2023
Q2 		$23.6K Sell
430
-160
-27% -$7.34K ﹤0.01% 5865
2023
Q1 		$25.4K Buy
+590
New +$28.5K ﹤0.01% 5355
2022
Q1 		– Sell
-30
Closed -$2K – 8244
2021
Q4 		$2K Buy
+30
New +$5.24K ﹤0.01% 7875
2021
Q3 		– Sell
-10
Closed -$3K – 8385
2021
Q2 		$3K Buy
+10
New +$2.99K ﹤0.01% 7868

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return